Blog

Bishal Gyawali: Patient perspectives on overtreatment, clinical trials, and quality of life

Bishal Gyawali/scri.queensu.ca

Sep 29, 2024, 17:04

Bishal Gyawali: Patient perspectives on overtreatment, clinical trials, and quality of life

Bishal Gyawali reposted on X:

“This is a brilliant and poignant piece highlighting patient perspectives on overtreatment, clinical trials, and quality of life. I hope many patients read this.”

Source: Bishal Gyawali/X

More posts featuring Bishal Gyawali on oncodaily.com

Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives.

Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.

ASCO’s Health Equity and Outcomes Committee Bishal Gyawali cancer OncoDaily Oncology Queen’s University WHO Essential Medicines List Cancer Medicines Working Group

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage